The pharmaceutical company, which has overseen a venture capital unit since 2004, will form the fund as it cuts internal neuroscience research.
Author: Robert Lavine
Intuity feels its way towards $70m
The Sarnoff spinoff will use the financing to commercialise its diabetes management and glucose measuring technology in the US.
AMI and Baidu board $200m mobility fund
The Apollo Southeast Asia fund will extend Baidu’s $1.5bn Apollo Fund, formed to support its autonomous driving technology, to a new region.
FAW moves to invest in Mobike Chuxing
The carmaker has taken a 10% stake in Mobike Chuxing, a car sharing spinoff launched by Mobike with more than $300m last month.
Agent finds $52m for first fund
Agent Capital, formed by Ex-Baxalta Ventures managing partner Geeta Vemuri, has raised $52m of a planned $150m for its first fund.
Corporates drive AImotive’s $38m series C round
The autonomous driving software developer, which also counts Nvidia as a backer, raised new funding from investors including Robert Bosch, Cisco and Samsung.
Renault-Nissan-Mitsubishi start up $200m fund
The strategic alliance will officially launch a $200m mobility-focused corporate venturing fund tomorrow at electronics trade show CES.
Big Deal: Didi Chuxing buys a 99
Didi Chuxing’s reported $600m acquisition of a majority stake in its Brazilian counterpart indicates a new level to its expansion plans.
BrightFunnel reaches its Terminus in acquisition deal
Terminus has bought BrightFunnel, a marketing analytics platform that had raised $9.5m from backers including Salesforce Ventures and Bloomberg Beta.
Splend finds its Element
Element Fleet Management has invested $5.7m for a 12.5% stake in car rental service Splend together with $173m in debt financing.
Corporate venturing deal net: 1-5 January 2018
IDfy, an India-based background verification services provider backed by e-commerce company Beenos, has secured Rs 195m ($3.1m) in a round that included New Enterprise Associates (NEA), NB Ventures, and Dream Incubator, VCCircle reported on Tuesday, citing people aware of the development. The round came after IDfy had received $3m in 2015 from Beenos, NEA, Faktory… Continue reading Corporate venturing deal net: 1-5 January 2018
Rewind fast forwards to series A
Rewind Therapeutics, which is developing therapies for myelin-related diseases like MS, secured $18.3m in a Boehringer Ingelheim and Merck Group-backed round.
PGDx passes test to raise $75m
Bristol Myers-Squibb co-led the genomic testing technology provider’s series B round, which will support the expansion of its cancer tests to patients.
Choushu confirms Google-backed round
The game livestreaming platform has now raised $120m in total, putting the round’s size closer to $42m than the $76.8m previously reported.